Health ❯Pharmaceuticals

Drug Approval

FDA FDA Regulations Regulatory Process Novo Nordisk Clinical Trials XPHOZAH Market Introduction Obesity Treatment Pain Management Nonopioid Painkillers Nerve Damage Rare Diseases FDA Drug Approval China Sickle Cell Disease Treatment Epinephrine

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Novo Nordisk Launches Wegovy in China at Lower Price Point

FDA Approves First At-Home Nasal Spray Flu Vaccine

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

FDA Approves Neffy: First Needle-Free Epinephrine Nasal Spray for Allergic Reactions

FDA Approves AstraZeneca and Ionis' Wainua for Rare Nerve Disease